{"gene":"ITGAL","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":1989,"finding":"CD11a/CD18 (LFA-1) mediates PMN adhesion to unstimulated endothelial cells by binding to ICAM-1; anti-CD11a and anti-ICAM-1 antibodies blocked the same ~50% of adhesion without additive effect, while CD11b/CD18 mediates adhesion via a distinct, non-ICAM-1 ligand. Interaction of CD11a/CD18 with surface-bound ICAM-1 caused selective down-modulation of CD11a/CD18 from the apical surface of macrophages.","method":"Monoclonal antibody blocking assays on PMN-endothelial cell adhesion; anti-ICAM-1 additive inhibition analysis; surface down-modulation on ICAM-1-coated surfaces","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal blocking experiments replicated across conditions, reciprocal inhibition analysis with additive antibody combinations, and functional down-modulation assay","pmids":["2809204"],"is_preprint":false},{"year":1991,"finding":"CD40 signaling in B cells activates CD11a/CD18 (LFA-1)-mediated homotypic adhesion; this activation requires CD40 cytoplasmic tail-mediated signaling (cells expressing CD40 lacking the cytoplasmic tail did not aggregate), is energy- and cation-dependent, and is blocked by anti-CD18 mAb. CD40 signaling also induces upregulation of ICAM-1 (CD54) on B cells.","method":"B cell aggregation assays with anti-CD40 mAb; comparison of full-length vs. cytoplasmic tail-truncated CD40-transfected mouse B cell lines; inhibitor studies (RNA/protein synthesis, anti-CD18 mAb)","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (truncation mutant) and pharmacological evidence, multiple cell lines, replicated with multiple inhibitors","pmids":["1706378"],"is_preprint":false},{"year":1991,"finding":"CD11a/CD18:ICAM-1 interactions are required for T cell–B cell collaboration leading to B cell proliferation and differentiation; anti-CD11a or anti-CD18 mAbs blocked B cell responses without directly inhibiting T cell DNA synthesis or IL-2 production, indicating CD11a on resting B cells interacts with ICAM-1 on activated CD4+ T cells.","method":"B cell proliferation/differentiation assays with blocking mAbs; T cell-independent activation controls; LFA-1-negative T cell clone controls; exogenous IL-2 rescue experiments","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple controls including LFA-1-deficient T cell clones and exogenous IL-2 rescue, replicated across conditions","pmids":["1670945"],"is_preprint":false},{"year":1992,"finding":"ICAM-2 serves as a second counter-receptor for CD11a/CD18 and provides T cell costimulatory signals; soluble ICAM-2-Ig fusion protein co-immobilized with anti-TCR mAb induced CD4+ T cell proliferation and IL-2R expression, and this costimulatory effect was almost completely inhibited by anti-CD11a or anti-CD18 mAbs.","method":"T cell proliferation assays with co-immobilized ICAM-2-Rg and anti-TCR mAb; blocking with anti-CD11a and anti-CD18 mAbs; CD25 expression analysis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ligand-receptor interaction demonstrated functionally with soluble Ig-fusion protein and replicated with blocking antibodies","pmids":["1346150"],"is_preprint":false},{"year":1992,"finding":"TCR complex crosslinking induces PKC-dependent association of CD11a/CD18 with the actin cytoskeleton; anti-CD3 mAb induced actin polymerization, colocalization of F-actin with LFA-1 by fluorescence microscopy, and LFA-1 immunoprecipitation from detergent-insoluble cytoskeletal fractions. This was blocked by the PKC inhibitor staurosporine or PKC desensitization, and accompanied by transient CD11a hyperphosphorylation.","method":"Fluorescence microscopy colocalization; immunoprecipitation from detergent-insoluble cytoskeletal fraction; PKC inhibitor (staurosporine); PKC desensitization; beta2-deficient T cell controls","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (microscopy, biochemical fractionation, IP, pharmacological inhibition, genetic controls)","pmids":["1346786"],"is_preprint":false},{"year":1992,"finding":"Triggering of CD11a (LFA-1 alpha chain) by specific mAbs, but not anti-LFA-1 beta chain mAbs, induces homotypic adhesion in pre-activated (but not resting) T cells via LFA-1 itself; this requires an intact cytoskeleton (inhibited by cytochalasin B) and is sensitive to H7 (PKC/PKA inhibitor), implicating cytoskeletal reorganization and kinase signaling in LFA-1 alpha chain-mediated inside-out signaling.","method":"T cell homotypic aggregation assays; blocking mAbs against CD11a, CD18, ICAM-1; cytochalasin B and H7 inhibitor studies; temperature and divalent cation dependence tests","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection with multiple inhibitors, single lab","pmids":["1352499"],"is_preprint":false},{"year":1993,"finding":"The CD11a gene promoter contains distinct cell-type-specific regulatory elements: the region -40 to -17 drives activity in T lymphocytes (Jurkat), and the first 17 bp relative to transcription start site drives activity in myeloid cells (HL-60); the 1.7 kb promoter is active only in leukocytes and not in non-leukocyte cell lines.","method":"Promoter cloning; transient expression assays with deletion reporter constructs in Jurkat, HL-60, and non-leukocyte cell lines","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional promoter deletion mapping in multiple cell lines, single lab","pmids":["8097887"],"is_preprint":false},{"year":1993,"finding":"The CD11a promoter contains a 'LYM' box binding lymphoid/preerythroid and myeloid cell-specific DNA-binding activities, and a 'GAGA' sequence (RRRGAGGAAG) binding MS-1 (myeloid-specific, likely Ets family) and MS-2 (broadly expressed but developmentally regulated in myeloid cells), which control myeloid and lymphoid expression of CD11a.","method":"Promoter cloning and characterization; DNA-protein binding assays (EMSA); transient expression assays in lymphoid and myeloid cell lines","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cis-element mapping combined with DNA-binding activity characterization, single lab","pmids":["8099450"],"is_preprint":false},{"year":1993,"finding":"A synthetic peptide from residues 21–42 of the first Ig domain of ICAM-2 binds directly to purified CD11a/CD18 and inhibits endothelial cell adhesion to this integrin, as well as B lymphoblastoid cell binding to endothelial cells, identifying the ICAM-2 D1 region as the CD11a/CD18 binding site.","method":"Direct binding of synthetic peptide to purified CD11a/CD18; adhesion inhibition assays; leukocyte binding to peptide-coated plastic","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical binding to purified integrin with functional adhesion inhibition, single lab with multiple assays","pmids":["8349630"],"is_preprint":false},{"year":1993,"finding":"CD11a/CD18 engagement enhances TNF-alpha and IL-2 mRNA expression (3- to 10-fold) in activated T cells; LFA-1-mediated homotypic aggregation and adhesion to ICAM-1 enhanced cytokine production, which was blocked by anti-CD11a, anti-CD18, or anti-ICAM-1 mAbs. Engagement of CD11a/CD18 on interaction with endothelial cells also enhanced cytokine production.","method":"Northern blot analysis of TNF-alpha mRNA; cytokine production assays; blocking with anti-CD11a, anti-CD18, anti-ICAM-1 mAbs; co-immobilized ICAM-1 adhesion assays","journal":"Cellular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional signaling assay with Northern blot readout and antibody inhibition, single lab","pmids":["8098668"],"is_preprint":false},{"year":1993,"finding":"CD11a promoter activity is negatively regulated by sequences between -880 and -226, while the proximal region shows tissue-specific activity; the major transcription initiation site resembles an 'initiator' sequence; the -880/+83 fragment confers tissue-specific expression to reporter genes in leukocyte vs. non-leukocyte cell lines.","method":"CD11a promoter isolation; identification of transcription start sites; transient reporter gene expression assays with deletion constructs in LFA1+ and LFA1- cell lines","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional promoter deletion mapping in multiple cell lines, single lab","pmids":["8103515"],"is_preprint":false},{"year":1996,"finding":"Crystal structures of the CD11a I-domain with no bound metal, bound Mg2+, and previously known Mn2+ show no major structural rearrangements at the metal-binding site; the cation-dependence of CD11a/CD18 ligand binding is therefore not explained by I-domain conformational change upon metal binding/removal, suggesting the metal ion participates directly in ligand contact or promotes favorable quaternary integrin arrangement.","method":"X-ray crystallography of CD11a I-domain with Mg2+ and without metal ion; structural comparison to previously solved Mn2+-bound structure","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures solved under multiple conditions with direct structural comparison; mechanistic interpretation supported by functional context","pmids":["8805579"],"is_preprint":false},{"year":1997,"finding":"Telencephalin (TLN/ICAM-5), a neuronal glycoprotein with NH2-terminal Ig domains homologous to ICAMs, is a cellular ligand for CD11a/CD18; T cells and B lymphoblastoid cells bound to immunopurified recombinant TLN via CD11a/CD18, and TLN-transfected L cells bound purified CD11a/CD18; binding was inhibited by anti-CD11a/CD18 antibody.","method":"Cell adhesion assays to immunopurified recombinant TLN; reciprocal binding of TLN-transfected L cells to purified CD11a/CD18; antibody blocking; domain deletion analysis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding assays with purified proteins and transfected cells, multiple cell types, antibody blocking","pmids":["8993013"],"is_preprint":false},{"year":1999,"finding":"Lovastatin binds to the I-domain of the CD11a alpha-chain, inhibiting LFA-1/ICAM-1 interaction; NMR spectroscopy and X-ray crystallography revealed the atomic details of lovastatin binding to the I-domain, representing an allosteric mechanism of LFA-1 inhibition distinct from ligand-competitive blocking.","method":"NMR spectroscopy; X-ray crystallography of lovastatin-I-domain complex; LFA-1/ICAM-1 interaction inhibition assays","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — two orthogonal structural methods (NMR + crystallography) with functional inhibition data in one study","pmids":["10493852"],"is_preprint":false},{"year":2000,"finding":"The first Ig domain of ICAM-5 (telencephalin) is required for CD11a/CD18 binding; protein constructs containing the first Ig domain supported CD11a/CD18 interaction, while deletion of the first domain abolished binding; mAbs against the first domain completely blocked interaction. T cell binding to rat hippocampal neurons was blocked by anti-CD11a/CD18 and anti-ICAM-5 mAbs.","method":"Domain deletion constructs of ICAM-5; binding assays to CD11a/CD18; monoclonal antibody blocking; human T cell binding to rat hippocampal neurons","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain mapping with multiple deletion constructs, antibody blocking, and primary neuron binding assay","pmids":["10741396"],"is_preprint":false},{"year":2000,"finding":"CD11a/CD18 mediates initial neutrophil capture to ICAM-1 under shear stress (formyl peptide stimulation boosted capture efficiency ~4-fold via CD11a/CD18), while CD11b/CD18 is required for stable aggregate formation over sustained shear; these are sequential, cooperative steps in neutrophil adhesion to ICAM-1.","method":"Cone-plate viscometer shear assays; two-color flow cytometry measurement of heterotypic aggregates; monoclonal antibody blockade of CD11a and CD11b; ICAM-1-transfected target cells","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — quantitative biophysical adhesion assay with selective antibody blockade, defined functional dissection of two integrin roles","pmids":["10648403"],"is_preprint":false},{"year":2000,"finding":"Truncated beta2 subunit variants terminating after Q444 are sufficient for LFA-1 (CD11a/CD18) surface expression; surface-expressed LFA-1 variants with truncated beta2 are constitutively active for ICAM-1 adhesion and express the activation reporter epitope of mAb 24, indicating the major cysteine-rich region and conserved cysteines at 445/447/449 are not required for surface expression but their removal leads to constitutive activation.","method":"Transfection of truncated beta2 variants; flow cytometry for surface expression; ICAM-1 adhesion assays; mAb 24 activation epitope detection","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — structure-function analysis with multiple truncation mutants and functional adhesion assay, single lab","pmids":["10946284"],"is_preprint":false},{"year":2001,"finding":"Endothelial cell-specific molecule-1 (ESM-1) binds directly to LFA-1 (CD11a/CD18) on lymphocytes, monocytes, and Jurkat cells; binding is divalent cation-dependent, saturable, and demonstrated by co-immunoprecipitation with anti-CD11a and anti-CD18 mAbs; real-time Biacore biosensor confirmed direct high-affinity interaction (Kd = 18.7 nM); ESM-1 dose-dependently inhibits soluble ICAM-1 binding to Jurkat cells.","method":"Co-immunoprecipitation with anti-CD11a and anti-CD18 mAbs; Biacore surface plasmon resonance kinetics; ICAM-1 competitive binding assay; Ca2+/Mg2+/Mn2+ dependence analysis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — cell-free Biacore assay with Kd measurement plus reciprocal co-IP in two orthogonal systems confirming direct binding","pmids":["11544294"],"is_preprint":false},{"year":2002,"finding":"Specific sequences flanking the ITGAL promoter (>500 bp 5' of transcription start site) are hypomethylated in lupus T cells and in T cells treated with 5-azacytidine or procainamide; patch methylation of this region suppresses ITGAL promoter function, demonstrating that DNA methylation changes at these sequences functionally regulate LFA-1 expression.","method":"Bisulfite sequencing of ITGAL promoter and flanking regions; patch methylation of promoter sequences in reporter constructs; T cells from lupus patients vs. healthy subjects","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 1 / Strong — functional patch methylation assay directly linking specific methylation changes to promoter activity, validated in primary human lupus T cells and in vitro model","pmids":["12115234"],"is_preprint":false},{"year":2002,"finding":"DNA methylation and chromatin structure contribute to tissue-specific CD11a expression; ITGAL promoter and 5' flanking regions are heavily methylated in fibroblasts (which do not express CD11a) but not in T cells; methylation correlates with closed chromatin (DNase I resistance); patch methylation of promoter and flanking regions suppresses ITGAL promoter function; treatment of fibroblasts with methylation inhibitor decreased promoter methylation and increased CD11a mRNA.","method":"Bisulfite sequencing; DNase I sensitivity assay; patch methylation of reporter constructs; 5-azacytidine treatment of fibroblasts; CD11a mRNA measurement","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal epigenetic methods with functional reporter assays and primary cell validation","pmids":["12036881"],"is_preprint":false},{"year":2002,"finding":"Lck tyrosine kinase is required for surface expression and activation of CD11a/CD18 in T cells; Lck-deficient Jurkat cells (JCaM1.6) showed dramatically reduced CD11a/CD18 surface expression, reduced CD3- and PMA-induced adhesion to ICAM-1, accumulation of immature (incompletely glycosylated) CD18 not associated with CD11a, and re-transfection of Lck restored adhesion. Src-family kinase inhibitor PP2 also inhibited CD3-induced adhesion at concentrations blocking MAP kinase pathway.","method":"Lck-deficient Jurkat cell line (JCaM1.6); PP2 kinase inhibitor; flow cytometry for surface expression; cell surface labeling; ICAM-1 adhesion assays; Lck reconstitution by transfection","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (Lck-deficient line), pharmacological inhibition, and genetic rescue (Lck re-expression) all converge on same conclusion","pmids":["12115650"],"is_preprint":false},{"year":2002,"finding":"Age-dependent hypomethylation of sequences flanking the ITGAL promoter correlates with increased CD11a mRNA expression in aging T cells; CD11a mRNA increases with age and with experimentally induced DNA hypomethylation; patch methylation of this region suppresses promoter function; DNA methyltransferases 1 and 3a decrease with aging.","method":"Bisulfite sequencing; patch methylation of promoter sequences in reporter constructs; CD11a mRNA measurement by RT-PCR; DNA methyltransferase activity measurement","journal":"Mechanisms of ageing and development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional patch methylation reporter assay plus correlation of methyltransferase levels with gene expression, single lab","pmids":["12020947"],"is_preprint":false},{"year":2003,"finding":"RUNX/AML and C/EBP factors regulate CD11a expression in myeloid cells through overlapping binding sites in the MS7 element of the CD11a promoter; C/EBP factors predominate in proliferating myeloid cells, while RUNX/AML factors (especially RUNX3/AML-2) bind in differentiated myeloid cells and increase CD11a/CD18 expression. AML-1/ETO inhibits CD11a promoter activity, explaining low CD11a/CD18 expression in t(8;21) myeloid leukemia cells.","method":"EMSA; ChIP; reporter gene assays with mutated MS7 elements; transfection of AML1B/CBFbeta and RUNX3; flow cytometry for CD11a/CD18 surface expression; comparison of myeloid cell lines and primary cells","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, EMSA, and functional reporter assays with mutants and overexpression, multiple transcription factors tested, mechanistic explanation validated in leukemia cells","pmids":["12855590"],"is_preprint":false},{"year":2003,"finding":"Ly6C cross-linking induces clustering of LFA-1 (CD11a/CD18) on CD8 T cell surfaces via a mechanism dependent on actin cytoskeleton reorganization and calpain (intracellular protease) activity, but not PI3-kinase; LFA-1 clustering augments lymphocyte adhesion to endothelium in a capillary flow assay, and this is blocked by anti-LFA-1 mAb.","method":"Ly6C cross-linking; fluorescence microscopy of LFA-1 clustering; pharmacological inhibitors (cytochalasin, calpain inhibitor, PI3-kinase inhibitor); capillary flow-adhesion assay with blocking anti-LFA-1 mAb","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection of pathway with functional adhesion readout, single lab","pmids":["12538687"],"is_preprint":false},{"year":2010,"finding":"RFX1 represses CD11a expression in CD4+ T cells by recruiting DNMT1, HDAC1, and histone methyltransferase SUV39H1 to the CD11a and CD70 promoters, maintaining DNA methylation, histone deacetylation, and H3K9 trimethylation; RFX1 downregulation in SLE reduces these repressive marks and causes CD11a overexpression. RFX1 co-immunoprecipitates with SUV39H1, and overexpressing/knocking down RFX1 controls H3K9me3 and CD11a expression levels.","method":"ChIP for H3K9me3 at CD11a promoter; co-immunoprecipitation of RFX1 and SUV39H1; RFX1 overexpression and siRNA knockdown; Western blot and immunofluorescence; RT-PCR for CD11a mRNA; SLE patient vs. healthy control CD4+ T cells","journal":"Journal of autoimmunity; Arthritis research & therapy","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, co-IP, and gain/loss-of-function experiments across two publications from same lab with orthogonal methods","pmids":["20223637","21192791"],"is_preprint":false},{"year":2013,"finding":"CD11a (ITGAL) is required for CD8+ T cell accumulation, activation, and proliferation in adipose tissue during obesity; CD11a-deficient obese mice showed dramatically reduced T cell infiltration, activation, and interferon-gamma expression in adipose tissue; adoptive transfer of CD11a-deficient CD8+ T cells failed to infiltrate adipose tissue of obese wild-type recipients, directly demonstrating a cell-intrinsic role for CD11a in T cell migration to adipose tissue.","method":"CD11a knockout mice; adoptive transfer of WT vs. CD11a-deficient CD8+ T cells; flow cytometry for T cell phenotype; in vitro stimulation with IL-12/IL-18; insulin resistance measurement","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout and adoptive transfer reconstitution experiment establish cell-intrinsic requirement, multiple orthogonal readouts","pmids":["24158516"],"is_preprint":false},{"year":2013,"finding":"CD11a deficiency in mice reduces the magnitude of the primary CD8 T cell response to Listeria monocytogenes, decreases differentiation into short-lived effector cells (KLRG1hi CD127lo), and greatly enhances generation of CD62L+ central memory cells; CD11b or CD11c deficiency had no effect, establishing a specific non-redundant role for CD11a in effector differentiation. Secondary responses were robust despite CD11a deficiency.","method":"CD11a-, CD11b-, and CD11c-deficient mice infected with L. monocytogenes; flow cytometry for KLRG1, CD127, CD62L, cytokine and granzyme B production","journal":"Infection and immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic comparison of three single-knockout strains establishes specificity, multiple phenotypic readouts with defined effector/memory markers","pmids":["23357382"],"is_preprint":false},{"year":2013,"finding":"Natural genetic variation in Itgal (including coding SNPs, a 5-bp insertion in exon 30b, and altered expression of a splice variant) modulates ischemic brain infarct volume; mice lacking Itgal showed increased neuronal cell death in ex vivo brain slice and in vivo focal cerebral ischemia models, placing CD11a in a pathway controlling neuroprotection after ischemia.","method":"Quantitative trait locus mapping; reciprocal recombinant congenic mice; SNP haplotype analysis; CD11a knockout mice in ex vivo brain slice and in vivo focal ischemia models","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — QTL mapping refined by genetic engineering, confirmed in multiple ischemia models with CD11a-deficient mice","pmids":["24130503"],"is_preprint":false},{"year":2017,"finding":"Histone demethylase JMJD3 regulates CD11a expression in lupus CD4+ T cells by removing H3K27me3 from the ITGAL promoter; SLE patients showed decreased H3K27me3 and increased JMJD3 binding at the ITGAL promoter; JMJD3 overexpression in healthy donor CD4+ T cells reduced H3K27me3 at the ITGAL promoter and upregulated CD11a expression; JMJD3 siRNA in SLE cells reversed these effects.","method":"ChIP for H3K27me3 and JMJD3 at ITGAL promoter; JMJD3 overexpression (pcDNA3.1-JMJD3 transfection); JMJD3 siRNA knockdown; RT-PCR for CD11a; SLE patient vs. healthy control T cells","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP with gain and loss of function experiments, orthogonal molecular readouts, validated in both patient and healthy donor cells","pmids":["28430662"],"is_preprint":false},{"year":2019,"finding":"LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) have distinct roles in neutrophil extravasation; using newly generated LFA-1 FRET (CD11a-YFP/CD18-CFP) and Mac-1 FRET mice with two-photon intravital imaging, LFA-1 was found to regulate neutrophil penetration through hotspot I (entry into the endothelial cell layer), while Mac-1 regulated transit through hotspot II (exit through basement membrane and pericyte sheath).","method":"Transgenic LFA-1 FRET (CD11a-YFP/CD18-CFP) and Mac-1 FRET mice; two-photon intravital imaging; transmission electron microscopy","journal":"Experimental & molecular medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — novel FRET knockin mice with in vivo imaging, spatiotemporal dissection of extravasation with electron microscopy validation","pmids":["30967528"],"is_preprint":false},{"year":2019,"finding":"A loss-of-function variant in Itgal (ITGAL/CD11a) in CC042 mice increases susceptibility to Salmonella Typhimurium infection; the causative role was confirmed by quantitative complementation test, indicating CD11a contributes to host defense against systemic Salmonella in a genetic background-dependent manner.","method":"F2 cross QTL mapping; quantitative complementation test with CD11a loss-of-function variant; bacterial load quantification; immune cell phenotyping","journal":"Infection and immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — complementation test directly confirms causality of Itgal variant, supported by QTL mapping","pmids":["31636138"],"is_preprint":false},{"year":2022,"finding":"CD11a expressed on glioma-associated microglia (GAM) is required for CX3CR1 (Cx3cr1) expression, CX3CL1-directed microglia motility, and CCL5 (glioma mitogen) production; CD11a-knockout microglia showed reduced Cx3cr1 expression and impaired CX3CL1-directed migration. In vivo, antibody-mediated CD11a inhibition reduced Nf1 optic glioma growth in mice.","method":"CD11a-knockout mouse microglia in vitro functional studies; anti-CD11a neutralizing antibody treatment of Nf1 optic glioma mice in vivo; RNAScope and immunohistochemistry; RNA-seq meta-analysis","journal":"Neuro-oncology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout microglia in vitro and antibody inhibition in vivo with defined molecular mechanism (Cx3cr1 expression and Ccl5 production), validated in human specimens","pmids":["34043012"],"is_preprint":false},{"year":2013,"finding":"Spermine-mediated suppression of LFA-1 expression is mechanistically linked to enhanced DNA methylation of the ITGAL promoter; inhibition of ornithine decarboxylase (reducing polyamines) decreased DNMT activity and enhanced ITGAL demethylation, increasing CD11a expression; spermine supplementation restored DNMT activity, enhanced ITGAL methylation, and reduced CD11a expression. Spermine acts by modulating the methyl donor SAM through effects on S-adenosyl-L-methionine decarboxylase.","method":"DFMO-mediated polyamine depletion; extracellular spermine supplementation; DNMT activity measurement; bisulfite sequencing of ITGAL promoter; CD11a protein expression (flow cytometry); SAM/decarboxylated-SAM manipulation; Western blot for Rap1","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological gain and loss of function with methylation and expression readouts, mechanistic pathway identified, single lab","pmids":["23418509"],"is_preprint":false},{"year":2009,"finding":"Genetic deficiency of ItgaL (CD11a) completely prevents autoimmune diabetes development in NOD/LtJ mice and prevents insulitis, but through a mechanism distinct from Itgb2 deficiency: ItgaL deficiency does not alter NOD T cell adhesion to or transmigration across islet endothelial cells; adoptive transfer of ItgaL-deficient splenocytes into NOD/Rag-1 mice failed to cause diabetes, indicating ItgaL is required for T cell activation rather than adhesion/trafficking in this context.","method":"Gene-targeted ItgaL-deficient NOD/LtJ mice; insulitis and diabetes incidence monitoring; in vitro hydrodynamic flow adhesion studies with islet microvascular endothelial cells; adoptive transfer into NOD/Rag-1 mice","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with adoptive transfer and in vitro adhesion assays mechanistically distinguishing ItgaL from Itgb2 function","pmids":["19223596"],"is_preprint":false}],"current_model":"ITGAL (CD11a) encodes the alpha-L subunit of the beta2-integrin LFA-1 (CD11a/CD18), which mediates leukocyte adhesion and immune cell activation by binding ligands ICAM-1, ICAM-2, ICAM-3, ICAM-5 (telencephalin), and ESM-1 through its I-domain (whose structure has been solved by X-ray crystallography and NMR, including a ligand-mimetic allosteric site targeted by lovastatin); inside-out activation of LFA-1 is regulated downstream of TCR signaling via PKC and Lck-dependent pathways that drive cytoskeletal association; CD11a expression is controlled at the transcriptional level by RUNX/AML and C/EBP transcription factors at the MS7 promoter element, and epigenetically by methylation of specific flanking ITGAL sequences (maintained by RFX1 recruiting DNMT1, HDAC1, and SUV39H1, and reversed by JMJD3-mediated H3K27 demethylation) that are aberrantly hypomethylated in SLE, aging, and systemic sclerosis leading to CD11a overexpression and autoreactivity; in vivo, CD11a plays defined roles in neutrophil capture at endothelial hotspot I during extravasation, CD8+ T cell effector differentiation and adipose tissue infiltration, microglia motility and glioma growth control, and protection against ischemic brain injury and Salmonella infection."},"narrative":{"mechanistic_narrative":"ITGAL encodes the alpha-L subunit (CD11a) that pairs with CD18 to form the beta2-integrin LFA-1, a central mediator of leukocyte adhesion, immune cell collaboration, and activation [PMID:2809204, PMID:1670945]. LFA-1 binds a family of immunoglobulin-superfamily counter-receptors through its CD11a I-domain: ICAM-1 [PMID:2809204], ICAM-2 (via the first Ig domain) [PMID:1346150, PMID:8349630], the neuronal ligand telencephalin/ICAM-5 (first Ig domain required) [PMID:8993013, PMID:10741396], and the soluble endothelial factor ESM-1, which binds with high affinity and competes with ICAM-1 [PMID:11544294]. Crystal and NMR structures of the I-domain established that cation dependence of ligand binding does not arise from metal-induced conformational change of the I-domain itself, and revealed an allosteric pocket where lovastatin binds to inhibit LFA-1/ICAM-1 engagement [PMID:8805579, PMID:10493852]. LFA-1 adhesiveness is controlled by inside-out signaling downstream of antigen-receptor and costimulatory inputs: TCR/CD3 crosslinking drives PKC-dependent association of CD11a/CD18 with the actin cytoskeleton [PMID:1346786], the Src-family kinase Lck is required for CD11a/CD18 surface expression and ICAM-1 adhesion [PMID:12115650], and CD40 signaling activates LFA-1-mediated homotypic adhesion in B cells [PMID:1706378]. Functional engagement of LFA-1 enhances T-cell cytokine output and supports T cell-B cell collaboration and costimulation [PMID:1670945, PMID:1346150, PMID:8098668]. ITGAL transcription is restricted to leukocytes through cell-type-specific proximal promoter elements and is driven in myeloid cells by RUNX/AML and C/EBP factors at the MS7 element [PMID:8097887, PMID:12855590], while DNA methylation of promoter-flanking sequences enforces tissue-restricted and quantitative control: this repressive state is maintained by RFX1-recruited DNMT1/HDAC1/SUV39H1 and by H3K27 trimethylation, and is reversed by JMJD3-mediated demethylation, with aberrant hypomethylation driving CD11a overexpression in lupus and aging T cells [PMID:12115234, PMID:12036881, PMID:20223637, PMID:21192791, PMID:28430662]. In vivo, CD11a directs neutrophil penetration of the endothelium during extravasation [PMID:10648403, PMID:30967528], CD8+ T cell effector differentiation and adipose-tissue infiltration [PMID:24158516, PMID:23357382], glioma-associated microglia motility and glioma growth [PMID:34043012], and host responses in ischemic brain injury and Salmonella infection [PMID:24130503, PMID:31636138], and its loss prevents autoimmune diabetes by impairing T cell activation rather than trafficking [PMID:19223596].","teleology":[{"year":1989,"claim":"Established the founding adhesive function of LFA-1 by showing CD11a/CD18 mediates leukocyte adhesion to endothelium specifically through ICAM-1, distinct from CD11b/CD18.","evidence":"Monoclonal antibody blocking of PMN-endothelial adhesion with additive-inhibition analysis and surface down-modulation assays","pmids":["2809204"],"confidence":"High","gaps":["Does not define the I-domain residues contacting ICAM-1","Does not address activation state of the integrin"]},{"year":1991,"claim":"Demonstrated that LFA-1 adhesion is actively induced by immune signaling, linking CD40 and TCR-dependent T cell-B cell interactions to functional adhesion and B cell responses.","evidence":"B cell aggregation assays with CD40 truncation mutants and anti-CD18 blockade; T-B collaboration assays with anti-CD11a/CD18 blockade and IL-2 rescue","pmids":["1706378","1670945"],"confidence":"High","gaps":["Intracellular signaling pathway from CD40 to LFA-1 not resolved","Does not identify the ligand on the partner cell biochemically"]},{"year":1992,"claim":"Identified ICAM-2 as a second counter-receptor that delivers costimulatory signals and showed TCR crosslinking drives PKC-dependent LFA-1 association with actin, defining inside-out activation.","evidence":"T cell proliferation with co-immobilized ICAM-2-Ig; fluorescence colocalization and cytoskeletal-fraction IP with PKC inhibition; CD11a-specific mAb-triggered aggregation","pmids":["1346150","1346786","1352499"],"confidence":"High","gaps":["Identity of cytoskeletal adaptors linking LFA-1 to actin not defined","Direct PKC substrate on the integrin tail not established"]},{"year":1993,"claim":"Mapped the ICAM-2 binding region to its first Ig domain and defined the leukocyte-restricted, cell-type-specific architecture of the ITGAL promoter.","evidence":"Synthetic-peptide binding to purified CD11a/CD18 with adhesion inhibition; promoter deletion/reporter mapping and EMSA in lymphoid vs myeloid cell lines; cytokine mRNA induction assays","pmids":["8349630","8097887","8099450","8103515","8098668"],"confidence":"High","gaps":["Specific trans-acting factors at proximal elements not all identified","Negative regulatory region between -880 and -226 mechanistically uncharacterized"]},{"year":1996,"claim":"Resolved that I-domain cation dependence is not explained by metal-induced I-domain rearrangement, refining the structural basis of ligand binding.","evidence":"X-ray crystallography of the CD11a I-domain with Mg2+ and metal-free, compared to Mn2+-bound structure","pmids":["8805579"],"confidence":"High","gaps":["Quaternary integrin rearrangement on activation not visualized","Does not capture ligand-bound I-domain conformation"]},{"year":1997,"claim":"Extended LFA-1's ligand repertoire to the nervous system by identifying telencephalin/ICAM-5 as a CD11a/CD18 ligand, later mapped to its first Ig domain.","evidence":"Adhesion of leukocytes to recombinant TLN and reciprocal binding of TLN-transfected cells; domain-deletion constructs and T cell binding to hippocampal neurons","pmids":["8993013","10741396"],"confidence":"High","gaps":["Physiological context of leukocyte-neuron LFA-1/ICAM-5 binding not defined","Affinity relative to ICAM-1/ICAM-2 not quantified"]},{"year":1999,"claim":"Defined a druggable allosteric site by determining lovastatin binds the I-domain to inhibit LFA-1/ICAM-1, distinct from competitive blockade.","evidence":"NMR and X-ray crystallography of the lovastatin-I-domain complex with functional inhibition assays","pmids":["10493852"],"confidence":"High","gaps":["In vivo relevance of statin binding to LFA-1 not addressed","Allosteric coupling to ligand site not structurally traced"]},{"year":2000,"claim":"Dissected the kinetics of adhesion, showing LFA-1 mediates initial neutrophil capture while constitutive activation can arise from beta2 cytoplasmic-region truncation.","evidence":"Shear-flow capture/aggregation assays with selective antibody blockade; transfection of truncated beta2 variants with mAb 24 activation-epitope detection","pmids":["10648403","10946284"],"confidence":"High","gaps":["Mechanism by which beta2 truncation triggers constitutive activation not resolved","Capture/stabilization handoff between LFA-1 and Mac-1 not molecularly defined"]},{"year":2001,"claim":"Identified ESM-1 as a soluble high-affinity LFA-1 ligand that competes with ICAM-1, implying a regulatory mode of adhesion control.","evidence":"Biacore SPR kinetics (Kd 18.7 nM), reciprocal co-IP with anti-CD11a/CD18, and ICAM-1 competition assays","pmids":["11544294"],"confidence":"High","gaps":["Physiological/in vivo role of ESM-1 antagonism of LFA-1 not established","Binding site on the I-domain not mapped"]},{"year":2002,"claim":"Established that DNA methylation of ITGAL promoter-flanking sequences functionally and quantitatively controls CD11a expression, and that this is dysregulated in lupus and aging; Lck was shown to be required for CD11a/CD18 surface expression and activation.","evidence":"Bisulfite sequencing, patch-methylation reporter assays, DNase-I sensitivity, and azacytidine treatment in lupus, fibroblast, and aging T cell systems; Lck-deficient Jurkat line with PP2 inhibition and Lck rescue","pmids":["12115234","12036881","12020947","12115650"],"confidence":"High","gaps":["Trans-acting machinery maintaining methylation not yet identified at this stage","How Lck loss blocks CD11a/CD18 surface assembly mechanistically unresolved"]},{"year":2003,"claim":"Defined transcription-factor control of CD11a in myeloid cells via RUNX/AML and C/EBP at the MS7 element, explaining repression by AML1/ETO, and showed Ly6C-triggered LFA-1 clustering augments adhesion.","evidence":"ChIP, EMSA, MS7-mutant reporters, and RUNX/CBFbeta overexpression with surface flow cytometry; Ly6C crosslinking with cytoskeletal and calpain inhibitors in a flow-adhesion assay","pmids":["12855590","12538687"],"confidence":"High","gaps":["Interplay between RUNX/C/EBP control and DNA methylation not integrated","Direct signaling intermediates of Ly6C-to-LFA-1 clustering not defined"]},{"year":2010,"claim":"Identified the repressive chromatin machinery, showing RFX1 recruits DNMT1, HDAC1, and SUV39H1 to maintain ITGAL methylation and H3K9me3, with loss driving lupus CD11a overexpression.","evidence":"ChIP for H3K9me3, RFX1-SUV39H1 co-IP, and RFX1 gain/loss-of-function in SLE vs control CD4+ T cells","pmids":["20223637","21192791"],"confidence":"High","gaps":["Upstream cause of RFX1 downregulation in SLE not established","Relative contribution of each recruited enzyme not separated"]},{"year":2013,"claim":"Defined non-redundant in vivo roles of CD11a in CD8+ T cell effector differentiation and adipose infiltration, in ischemic neuroprotection, in polyamine-linked methylation control, and in T cell activation underlying autoimmune diabetes.","evidence":"CD11a/CD11b/CD11c knockout mice in Listeria infection and obesity with adoptive transfer; QTL mapping and ischemia models; DFMO/spermine manipulation of DNMT activity and ITGAL methylation; ItgaL-deficient NOD mice with transfer and endothelial adhesion assays","pmids":["23357382","24158516","24130503","23418509","19223596"],"confidence":"High","gaps":["Tissue-specific ligand engagements driving each in vivo phenotype not all defined","How adhesion-independent CD11a contributes to T cell activation in diabetes unresolved"]},{"year":2017,"claim":"Added the H3K27 axis to ITGAL epigenetic control, showing JMJD3 demethylates the promoter to upregulate CD11a in lupus T cells.","evidence":"ChIP for H3K27me3 and JMJD3 with JMJD3 overexpression and siRNA in SLE and healthy CD4+ T cells","pmids":["28430662"],"confidence":"High","gaps":["Trigger for increased JMJD3 recruitment in SLE not identified","Interplay between H3K27 and DNA-methylation control not integrated"]},{"year":2019,"claim":"Spatially resolved LFA-1's extravasation role and confirmed a genetic requirement in host defense, separating LFA-1 (endothelial penetration) from Mac-1 (basement-membrane transit) and establishing causal Itgal contribution to Salmonella susceptibility.","evidence":"LFA-1 and Mac-1 FRET knockin mice with two-photon intravital imaging and TEM; QTL mapping with quantitative complementation of an Itgal loss-of-function variant","pmids":["30967528","31636138"],"confidence":"High","gaps":["Endothelial ligands distinguishing hotspot I from hotspot II not defined","Mechanism by which CD11a affects Salmonella defense unresolved"]},{"year":2022,"claim":"Revealed a cell-intrinsic CD11a program in glioma-associated microglia controlling CX3CR1 expression, CX3CL1-directed motility, CCL5 production, and tumor growth.","evidence":"CD11a-knockout microglia in vitro and anti-CD11a antibody treatment of Nf1 optic glioma mice with RNAScope/IHC and human-specimen validation","pmids":["34043012"],"confidence":"High","gaps":["Signaling link from CD11a to Cx3cr1 transcription not defined","Ligand engaged by microglial CD11a in the glioma microenvironment unknown"]},{"year":null,"claim":"How distinct ligand engagements (ICAM-1/2, ICAM-5, ESM-1) are selected in specific tissues and how inside-out signaling, conformational activation, and ligand competition are integrated to produce the diverse in vivo functions of CD11a remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking activation state to tissue-specific ligand choice","Mechanistic basis of adhesion-independent CD11a roles in T cell activation not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,3,12,15,17]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,3,9]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,4,16,20,23]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,2,25,26,33]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[18,22,24,28]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[19,24,28]}],"complexes":["LFA-1 (CD11a/CD18)"],"partners":["ITGB2","ICAM1","ICAM2","ICAM5","ESM1","LCK","RFX1","SUV39H1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P20701","full_name":"Integrin alpha-L","aliases":["CD11 antigen-like family member A","Leukocyte adhesion glycoprotein LFA-1 alpha chain","LFA-1A","Leukocyte function-associated molecule 1 alpha chain"],"length_aa":1170,"mass_kda":128.8,"function":"Integrin ITGAL/ITGB2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4 (PubMed:10846180, PubMed:12526797, PubMed:1676048, PubMed:3086451). Integrin ITGAL/ITGB2 is a receptor for F11R (PubMed:11812992, PubMed:15528364). Integrin ITGAL/ITGB2 is a receptor for the secreted form of ubiquitin-like protein ISG15; the interaction is mediated by ITGAL (PubMed:29100055). Involved in a variety of immune phenomena including leukocyte-endothelial cell interaction, cytotoxic T-cell mediated killing, and antibody dependent killing by granulocytes and monocytes. Contributes to natural killer cell cytotoxicity (PubMed:15356110). Involved in leukocyte adhesion and transmigration of leukocytes including T-cells and neutrophils (PubMed:11812992). Acts as a platform at the immunological synapse to translate TCR engagement and density of the ITGAL ligand ICAM1 into graded adhesion (PubMed:38195629). Required for generation of common lymphoid progenitor cells in bone marrow, indicating a role in lymphopoiesis (By similarity). Integrin ITGAL/ITGB2 in association with ICAM3, contributes to apoptotic neutrophil phagocytosis by macrophages (PubMed:23775590). Integrins ITGAL:ITGB2 functions as a receptor of the neuron-specific adhesion molecule ICAM5 ensuring neuron cell-leukocyte adhesion (PubMed:10741396). Integrin ITGAL/ITGB2 that functions as a signaling receptor of ICAM2, ensuring leukocyte cell-cell adhesion on resting cells (PubMed:1676048)","subcellular_location":"Cell membrane; Membrane raft","url":"https://www.uniprot.org/uniprotkb/P20701/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ITGAL","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ITGAL","total_profiled":1310},"omim":[{"mim_id":"605984","title":"EMBRYONIC ECTODERM DEVELOPMENT; EED","url":"https://www.omim.org/entry/605984"},{"mim_id":"605397","title":"CD226 ANTIGEN; CD226","url":"https://www.omim.org/entry/605397"},{"mim_id":"604762","title":"SWITCH-ASSOCIATED PROTEIN 70","url":"https://www.omim.org/entry/604762"},{"mim_id":"603735","title":"AMINE OXIDASE, COPPER-CONTAINING, 3; AOC3","url":"https://www.omim.org/entry/603735"},{"mim_id":"602856","title":"REGULATOR OF G PROTEIN SIGNALING 10; RGS10","url":"https://www.omim.org/entry/602856"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":34.9},{"tissue":"lymphoid tissue","ntpm":58.7}],"url":"https://www.proteinatlas.org/search/ITGAL"},"hgnc":{"alias_symbol":["HNA-5","LFA-1","LFA1A"],"prev_symbol":["CD11A"]},"alphafold":{"accession":"P20701","domains":[{"cath_id":"2.130.10.130","chopping":"35-138_361-612","consensus_level":"medium","plddt":93.2811,"start":35,"end":612},{"cath_id":"3.40.50.410","chopping":"156-316","consensus_level":"high","plddt":92.671,"start":156,"end":316},{"cath_id":"2.60.40.1460","chopping":"616-737_750-766","consensus_level":"high","plddt":80.8796,"start":616,"end":766},{"cath_id":"2.60.40.1510","chopping":"782-911","consensus_level":"high","plddt":80.324,"start":782,"end":911},{"cath_id":"2.60.40.1530","chopping":"924-1005_1013-1084","consensus_level":"high","plddt":81.0779,"start":924,"end":1084}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P20701","model_url":"https://alphafold.ebi.ac.uk/files/AF-P20701-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P20701-F1-predicted_aligned_error_v6.png","plddt_mean":82.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ITGAL","jax_strain_url":"https://www.jax.org/strain/search?query=ITGAL"},"sequence":{"accession":"P20701","fasta_url":"https://rest.uniprot.org/uniprotkb/P20701.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P20701/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P20701"}},"corpus_meta":[{"pmid":"16380428","id":"PMC_16380428","title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a).","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16380428","citation_count":370,"is_preprint":false},{"pmid":"12115234","id":"PMC_12115234","title":"Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus.","date":"2002","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/12115234","citation_count":222,"is_preprint":false},{"pmid":"2809204","id":"PMC_2809204","title":"Two leukocyte receptors (CD11a/CD18 and CD11b/CD18) mediate transient adhesion to endothelium by binding to different ligands.","date":"1989","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2809204","citation_count":222,"is_preprint":false},{"pmid":"1706378","id":"PMC_1706378","title":"CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1706378","citation_count":218,"is_preprint":false},{"pmid":"11544294","id":"PMC_11544294","title":"Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11544294","citation_count":214,"is_preprint":false},{"pmid":"10493852","id":"PMC_10493852","title":"Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10493852","citation_count":200,"is_preprint":false},{"pmid":"12020219","id":"PMC_12020219","title":"Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.","date":"2002","source":"Archives of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/12020219","citation_count":182,"is_preprint":false},{"pmid":"10688712","id":"PMC_10688712","title":"Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis.","date":"2000","source":"Journal of the American Academy of Dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/10688712","citation_count":166,"is_preprint":false},{"pmid":"1346786","id":"PMC_1346786","title":"Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/CD18-cytoskeleton association in T lymphocytes.","date":"1992","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1346786","citation_count":143,"is_preprint":false},{"pmid":"2459196","id":"PMC_2459196","title":"Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies.","date":"1988","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2459196","citation_count":143,"is_preprint":false},{"pmid":"20223637","id":"PMC_20223637","title":"Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells.","date":"2010","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/20223637","citation_count":135,"is_preprint":false},{"pmid":"8805579","id":"PMC_8805579","title":"The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin.","date":"1996","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/8805579","citation_count":128,"is_preprint":false},{"pmid":"7686816","id":"PMC_7686816","title":"Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.","date":"1993","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7686816","citation_count":122,"is_preprint":false},{"pmid":"1346150","id":"PMC_1346150","title":"Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells.","date":"1992","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1346150","citation_count":121,"is_preprint":false},{"pmid":"10648403","id":"PMC_10648403","title":"Sequential binding of CD11a/CD18 and CD11b/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule-1.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10648403","citation_count":109,"is_preprint":false},{"pmid":"7810691","id":"PMC_7810691","title":"Role of CD11a and CD11b in ischemic acute renal failure in rats.","date":"1994","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7810691","citation_count":106,"is_preprint":false},{"pmid":"10826130","id":"PMC_10826130","title":"Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis.","date":"1999","source":"Journal of pharmacokinetics and biopharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/10826130","citation_count":103,"is_preprint":false},{"pmid":"8100190","id":"PMC_8100190","title":"Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis.","date":"1993","source":"Clinical immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/8100190","citation_count":96,"is_preprint":false},{"pmid":"7499503","id":"PMC_7499503","title":"Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis.","date":"1995","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/7499503","citation_count":92,"is_preprint":false},{"pmid":"12020947","id":"PMC_12020947","title":"Age-dependent DNA methylation changes in the ITGAL (CD11a) promoter.","date":"2002","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/12020947","citation_count":88,"is_preprint":false},{"pmid":"1670945","id":"PMC_1670945","title":"The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1670945","citation_count":88,"is_preprint":false},{"pmid":"8993013","id":"PMC_8993013","title":"The neuronal glycoprotein telencephalin is a cellular ligand for the CD11a/CD18 leukocyte integrin.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8993013","citation_count":86,"is_preprint":false},{"pmid":"12207338","id":"PMC_12207338","title":"Bacterial fimbriae activate human peripheral blood monocytes utilizing TLR2, CD14 and CD11a/CD18 as cellular receptors.","date":"2002","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12207338","citation_count":78,"is_preprint":false},{"pmid":"16433753","id":"PMC_16433753","title":"LFA-1 (CD11a) as a therapeutic target.","date":"2006","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/16433753","citation_count":74,"is_preprint":false},{"pmid":"30967528","id":"PMC_30967528","title":"LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) distinctly regulate neutrophil extravasation through hotspots I and II.","date":"2019","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30967528","citation_count":73,"is_preprint":false},{"pmid":"1979068","id":"PMC_1979068","title":"Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes.","date":"1990","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/1979068","citation_count":73,"is_preprint":false},{"pmid":"30237316","id":"PMC_30237316","title":"The down-regulation of hsa_circ_0012919, the sponge for miR-125a-3p, contributes to DNA methylation of CD11a and CD70 in CD4+ T cells of systemic lupus erythematous.","date":"2018","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/30237316","citation_count":73,"is_preprint":false},{"pmid":"8132319","id":"PMC_8132319","title":"Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria.","date":"1994","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/8132319","citation_count":71,"is_preprint":false},{"pmid":"21192791","id":"PMC_21192791","title":"RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1.","date":"2010","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21192791","citation_count":68,"is_preprint":false},{"pmid":"1694134","id":"PMC_1694134","title":"Induction of cell-associated interleukin 1 through stimulation of the adhesion-promoting proteins LFA-1 (CD11a/CD18) and CR3 (CD11b/CD18) of human monocytes.","date":"1990","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1694134","citation_count":65,"is_preprint":false},{"pmid":"25414732","id":"PMC_25414732","title":"Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis.","date":"2014","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/25414732","citation_count":64,"is_preprint":false},{"pmid":"9645379","id":"PMC_9645379","title":"Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9645379","citation_count":64,"is_preprint":false},{"pmid":"8349630","id":"PMC_8349630","title":"A peptide from ICAM-2 binds to the leukocyte integrin CD11a/CD18 and inhibits endothelial cell adhesion.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8349630","citation_count":61,"is_preprint":false},{"pmid":"8094958","id":"PMC_8094958","title":"Effect of inhibitors of distinct signalling pathways on neutrophil Q2- generation in response to tumor necrosis factor-alpha, and antibodies against CD18 and CD11a: evidence for a common and unique pattern of sensitivity to wortmannin and protein tyrosine kinase inhibitors.","date":"1993","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8094958","citation_count":60,"is_preprint":false},{"pmid":"9637488","id":"PMC_9637488","title":"Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9637488","citation_count":59,"is_preprint":false},{"pmid":"24158516","id":"PMC_24158516","title":"Essential role of CD11a in CD8+ T-cell accumulation and activation in adipose tissue.","date":"2013","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24158516","citation_count":58,"is_preprint":false},{"pmid":"12036881","id":"PMC_12036881","title":"Effect of DNA methylation and chromatin structure on ITGAL expression.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12036881","citation_count":55,"is_preprint":false},{"pmid":"7678632","id":"PMC_7678632","title":"Generation and characterization of monoclonal antibodies against rabbit CD4, CD5 and CD11a antigens.","date":"1993","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/7678632","citation_count":55,"is_preprint":false},{"pmid":"7722533","id":"PMC_7722533","title":"Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks.","date":"1995","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/7722533","citation_count":55,"is_preprint":false},{"pmid":"1683677","id":"PMC_1683677","title":"Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade.","date":"1991","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/1683677","citation_count":54,"is_preprint":false},{"pmid":"10741396","id":"PMC_10741396","title":"Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10741396","citation_count":52,"is_preprint":false},{"pmid":"10946284","id":"PMC_10946284","title":"Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and function.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10946284","citation_count":52,"is_preprint":false},{"pmid":"8099450","id":"PMC_8099450","title":"Identification of cell-specific and developmentally regulated nuclear factors that direct myeloid and lymphoid expression of the CD11a gene.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8099450","citation_count":51,"is_preprint":false},{"pmid":"18239614","id":"PMC_18239614","title":"Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness.","date":"2008","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/18239614","citation_count":50,"is_preprint":false},{"pmid":"1681812","id":"PMC_1681812","title":"T lymphocyte adhesion to human synovial fibroblasts. Role of cytokines and the interaction between intercellular adhesion molecule 1 and CD11a/CD18.","date":"1991","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/1681812","citation_count":50,"is_preprint":false},{"pmid":"8620513","id":"PMC_8620513","title":"CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.","date":"1996","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8620513","citation_count":48,"is_preprint":false},{"pmid":"8611722","id":"PMC_8611722","title":"Total cell content of CR3 (CD11b/CD18) and LFA-1 (CD11a/CD18) in neonatal neutrophils: relationship to gestational age.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8611722","citation_count":46,"is_preprint":false},{"pmid":"10527686","id":"PMC_10527686","title":"Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis.","date":"1999","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/10527686","citation_count":43,"is_preprint":false},{"pmid":"16313368","id":"PMC_16313368","title":"NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation.","date":"2005","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16313368","citation_count":43,"is_preprint":false},{"pmid":"30588668","id":"PMC_30588668","title":"CD11a expression distinguishes infiltrating myeloid cells from plaque-associated microglia in Alzheimer's disease.","date":"2018","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/30588668","citation_count":42,"is_preprint":false},{"pmid":"8679214","id":"PMC_8679214","title":"Hyperoxia induces platelet activation and lung sequestration: an event dependent on tumor necrosis factor-alpha and CD11a.","date":"1996","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8679214","citation_count":41,"is_preprint":false},{"pmid":"12855590","id":"PMC_12855590","title":"RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12855590","citation_count":40,"is_preprint":false},{"pmid":"22519907","id":"PMC_22519907","title":"Moderate-intensity, premeal cycling blunts postprandial increases in monocyte cell surface CD18 and CD11a and endothelial microparticles following a high-fat meal in young adults.","date":"2012","source":"Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/22519907","citation_count":40,"is_preprint":false},{"pmid":"12823280","id":"PMC_12823280","title":"Up-regulation of ICAM-1, CD11a/CD18 and CD11c/CD18 on human THP-1 monocytes stimulated by Streptococcus suis serotype 2.","date":"2003","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12823280","citation_count":40,"is_preprint":false},{"pmid":"8097887","id":"PMC_8097887","title":"Description of the leukocyte function-associated antigen 1 (LFA-1 or CD11a) promoter.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8097887","citation_count":39,"is_preprint":false},{"pmid":"8103515","id":"PMC_8103515","title":"Characterization of the CD11a (alpha L, LFA-1 alpha) integrin gene promoter.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8103515","citation_count":38,"is_preprint":false},{"pmid":"12538687","id":"PMC_12538687","title":"Ly6C induces clustering of LFA-1 (CD11a/CD18) and is involved in subtype-specific adhesion of CD8 T cells.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12538687","citation_count":38,"is_preprint":false},{"pmid":"1352710","id":"PMC_1352710","title":"Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity.","date":"1992","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/1352710","citation_count":37,"is_preprint":false},{"pmid":"23357382","id":"PMC_23357382","title":"CD11a regulates effector CD8 T cell differentiation and central memory development in response to infection with Listeria monocytogenes.","date":"2013","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23357382","citation_count":35,"is_preprint":false},{"pmid":"1348286","id":"PMC_1348286","title":"Expression of the CD54 (ICAM-1) and CD11a (LFA-1) adhesion molecules in oral mucosal inflammation.","date":"1992","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/1348286","citation_count":35,"is_preprint":false},{"pmid":"11950807","id":"PMC_11950807","title":"Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent.","date":"2002","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/11950807","citation_count":35,"is_preprint":false},{"pmid":"10852588","id":"PMC_10852588","title":"Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients.","date":"2000","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/10852588","citation_count":35,"is_preprint":false},{"pmid":"8099567","id":"PMC_8099567","title":"A new CD43 monoclonal antibody induces homotypic aggregation of human leucocytes through a CD11a/CD18-dependent and -independent mechanism.","date":"1993","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8099567","citation_count":35,"is_preprint":false},{"pmid":"28662951","id":"PMC_28662951","title":"CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination.","date":"2017","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/28662951","citation_count":34,"is_preprint":false},{"pmid":"12064914","id":"PMC_12064914","title":"The \"ex vivo\" patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR expression identify acute/early and chronic/late NK-cell activation states.","date":"2002","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12064914","citation_count":33,"is_preprint":false},{"pmid":"8566043","id":"PMC_8566043","title":"Identification of Sp1-binding sites in the CD11c (p150,95 alpha) and CD11a (LFA-1 alpha) integrin subunit promoters and their involvement in the tissue-specific expression of CD11c.","date":"1995","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8566043","citation_count":33,"is_preprint":false},{"pmid":"12831828","id":"PMC_12831828","title":"Immune cell CD62L and CD11a expression in response to a psychological stressor in human hypertension.","date":"2003","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12831828","citation_count":31,"is_preprint":false},{"pmid":"12115650","id":"PMC_12115650","title":"Lck tyrosine kinase is important for activation of the CD11a/CD18-integrins in human T lymphocytes.","date":"2002","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12115650","citation_count":31,"is_preprint":false},{"pmid":"33186542","id":"PMC_33186542","title":"COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a+.","date":"2020","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33186542","citation_count":31,"is_preprint":false},{"pmid":"2565929","id":"PMC_2565929","title":"Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targets.","date":"1989","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2565929","citation_count":31,"is_preprint":false},{"pmid":"7902997","id":"PMC_7902997","title":"Quantitative analysis of lymphocyte CD11a using standardized flow cytometry.","date":"1993","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7902997","citation_count":31,"is_preprint":false},{"pmid":"10541054","id":"PMC_10541054","title":"CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects.","date":"1999","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/10541054","citation_count":30,"is_preprint":false},{"pmid":"15673599","id":"PMC_15673599","title":"Tissue distribution and receptor-mediated clearance of anti-CD11a antibody in mice.","date":"2005","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/15673599","citation_count":29,"is_preprint":false},{"pmid":"1730867","id":"PMC_1730867","title":"Regulation of expression of the leukocyte integrin CD11a (LFA-1) molecule during differentiation of HL-60 cells along the monocyte/macrophage pathway.","date":"1992","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1730867","citation_count":28,"is_preprint":false},{"pmid":"8656013","id":"PMC_8656013","title":"Engagement of adhesion molecules (CD18, CD11a, CD45, CD44, and CD58) enhances human immunodeficiency virus type 1 replication in monocytic cells through a tumor necrosis factor-modulated pathway.","date":"1996","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/8656013","citation_count":28,"is_preprint":false},{"pmid":"34043012","id":"PMC_34043012","title":"RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.","date":"2022","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34043012","citation_count":27,"is_preprint":false},{"pmid":"9885904","id":"PMC_9885904","title":"CD45RA(bright)/CD11a(bright) CD8+ T cells: effector T cells.","date":"1998","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9885904","citation_count":27,"is_preprint":false},{"pmid":"31426806","id":"PMC_31426806","title":"Transcriptome profiling of brain myeloid cells revealed activation of Itgal, Trem1, and Spp1 in western diet-induced obesity.","date":"2019","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/31426806","citation_count":26,"is_preprint":false},{"pmid":"14695458","id":"PMC_14695458","title":"Increased expression of monocyte CD11a and intracellular adhesion molecule-1 in patients with initial atherosclerotic coronary stenosis.","date":"2004","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/14695458","citation_count":26,"is_preprint":false},{"pmid":"28430662","id":"PMC_28430662","title":"Histone demethylase JMJD3 regulates CD11a expression through changes in histone H3K27 tri-methylation levels in CD4+ T cells of patients with systemic lupus erythematosus.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28430662","citation_count":26,"is_preprint":false},{"pmid":"8620558","id":"PMC_8620558","title":"Selective induction of CD11a,b,c/CD18 and CD54 expression at the cell surface of human leukocytes by muramyl peptides.","date":"1996","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8620558","citation_count":25,"is_preprint":false},{"pmid":"10087180","id":"PMC_10087180","title":"Critical role of CD11a (LFA-1) in therapeutic efficacy of systemically transferred antitumor effector T cells.","date":"1999","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10087180","citation_count":25,"is_preprint":false},{"pmid":"24130503","id":"PMC_24130503","title":"Natural genetic variation of integrin alpha L (Itgal) modulates ischemic brain injury in stroke.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24130503","citation_count":24,"is_preprint":false},{"pmid":"10882733","id":"PMC_10882733","title":"Polyomavirus enhancer-binding protein 2/core binding factor/acute myeloid leukemia factors contribute to the cell type-specific activity of the CD11a integrin gene promoter.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10882733","citation_count":24,"is_preprint":false},{"pmid":"1352499","id":"PMC_1352499","title":"Induction of homotypic T cell adhesion by triggering of leukocyte function-associated antigen-1 alpha (CD11a): differential effects on resting and activated T cells.","date":"1992","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1352499","citation_count":24,"is_preprint":false},{"pmid":"7516231","id":"PMC_7516231","title":"Polymorphonuclear granulocyte expression of CD11a/CD18, CD11b/CD18 and L-selectin in normal individuals.","date":"1994","source":"FEMS immunology and medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/7516231","citation_count":23,"is_preprint":false},{"pmid":"11577149","id":"PMC_11577149","title":"Porins from Salmonella enterica serovar Typhimurium induce TNF-alpha, IL-6 and IL-8 release by CD14-independent and CD11a/CD18-dependent mechanisms.","date":"2001","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11577149","citation_count":23,"is_preprint":false},{"pmid":"10531396","id":"PMC_10531396","title":"Neutrophil inhibitory factor abrogates neutrophil adhesion by blockade of CD11a and CD11b beta(2) integrins.","date":"1999","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10531396","citation_count":22,"is_preprint":false},{"pmid":"1718027","id":"PMC_1718027","title":"Functional epitope analysis of the human CD11a/CD18 molecule (LFA-1, lymphocyte function-associated antigen 1) involved in HIV-1-induced syncytium formation.","date":"1991","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1718027","citation_count":22,"is_preprint":false},{"pmid":"31636138","id":"PMC_31636138","title":"A Loss-of-Function Mutation in the Integrin Alpha L (Itgal) Gene Contributes to Susceptibility to Salmonella enterica Serovar Typhimurium Infection in Collaborative Cross Strain CC042.","date":"2019","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31636138","citation_count":21,"is_preprint":false},{"pmid":"12799043","id":"PMC_12799043","title":"Small molecule LFA-1 antagonists compete with an anti-LFA-1 monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assay.","date":"2003","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/12799043","citation_count":21,"is_preprint":false},{"pmid":"19223596","id":"PMC_19223596","title":"Genetic deficiency of Itgb2 or ItgaL prevents autoimmune diabetes through distinctly different mechanisms in NOD/LtJ mice.","date":"2009","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/19223596","citation_count":20,"is_preprint":false},{"pmid":"8098668","id":"PMC_8098668","title":"CD11a/CD18 (LFA-1) integrin engagement enhances biosynthesis of early cytokines by activated T cells.","date":"1993","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8098668","citation_count":20,"is_preprint":false},{"pmid":"18760844","id":"PMC_18760844","title":"Selective CD11a upregulation on neutrophils in the acute phase of steroid-responsive meningitis-arteritis in dogs.","date":"2008","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/18760844","citation_count":20,"is_preprint":false},{"pmid":"20884890","id":"PMC_20884890","title":"VEGF₁₆₄ differentially regulates neutrophil and T cell adhesion through ItgaL- and ItgaM-dependent mechanisms.","date":"2010","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20884890","citation_count":19,"is_preprint":false},{"pmid":"23418509","id":"PMC_23418509","title":"Suppression of LFA-1 expression by spermine is associated with enhanced methylation of ITGAL, the LFA-1 promoter area.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23418509","citation_count":19,"is_preprint":false},{"pmid":"16164020","id":"PMC_16164020","title":"RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters.","date":"2005","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16164020","citation_count":19,"is_preprint":false},{"pmid":"39885580","id":"PMC_39885580","title":"Extracellular vesicle surface engineering with integrins (ITGAL & ITGB2) to specifically target ICAM-1-expressing endothelial cells.","date":"2025","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/39885580","citation_count":18,"is_preprint":false},{"pmid":"23160181","id":"PMC_23160181","title":"Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL.","date":"2012","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/23160181","citation_count":18,"is_preprint":false},{"pmid":"29066026","id":"PMC_29066026","title":"CD4+CD28+KIR+CD11ahi T cells correlate with disease activity and are characterized by a pro-inflammatory epigenetic and transcriptional profile in lupus patients.","date":"2017","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/29066026","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53692,"output_tokens":9690,"usd":0.153213,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19944,"output_tokens":5722,"usd":0.121385,"stage2_stop_reason":"end_turn"},"total_usd":0.274598,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"CD11a/CD18 (LFA-1) mediates PMN adhesion to unstimulated endothelial cells by binding to ICAM-1; anti-CD11a and anti-ICAM-1 antibodies blocked the same ~50% of adhesion without additive effect, while CD11b/CD18 mediates adhesion via a distinct, non-ICAM-1 ligand. Interaction of CD11a/CD18 with surface-bound ICAM-1 caused selective down-modulation of CD11a/CD18 from the apical surface of macrophages.\",\n      \"method\": \"Monoclonal antibody blocking assays on PMN-endothelial cell adhesion; anti-ICAM-1 additive inhibition analysis; surface down-modulation on ICAM-1-coated surfaces\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal blocking experiments replicated across conditions, reciprocal inhibition analysis with additive antibody combinations, and functional down-modulation assay\",\n      \"pmids\": [\"2809204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"CD40 signaling in B cells activates CD11a/CD18 (LFA-1)-mediated homotypic adhesion; this activation requires CD40 cytoplasmic tail-mediated signaling (cells expressing CD40 lacking the cytoplasmic tail did not aggregate), is energy- and cation-dependent, and is blocked by anti-CD18 mAb. CD40 signaling also induces upregulation of ICAM-1 (CD54) on B cells.\",\n      \"method\": \"B cell aggregation assays with anti-CD40 mAb; comparison of full-length vs. cytoplasmic tail-truncated CD40-transfected mouse B cell lines; inhibitor studies (RNA/protein synthesis, anti-CD18 mAb)\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (truncation mutant) and pharmacological evidence, multiple cell lines, replicated with multiple inhibitors\",\n      \"pmids\": [\"1706378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"CD11a/CD18:ICAM-1 interactions are required for T cell–B cell collaboration leading to B cell proliferation and differentiation; anti-CD11a or anti-CD18 mAbs blocked B cell responses without directly inhibiting T cell DNA synthesis or IL-2 production, indicating CD11a on resting B cells interacts with ICAM-1 on activated CD4+ T cells.\",\n      \"method\": \"B cell proliferation/differentiation assays with blocking mAbs; T cell-independent activation controls; LFA-1-negative T cell clone controls; exogenous IL-2 rescue experiments\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple controls including LFA-1-deficient T cell clones and exogenous IL-2 rescue, replicated across conditions\",\n      \"pmids\": [\"1670945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"ICAM-2 serves as a second counter-receptor for CD11a/CD18 and provides T cell costimulatory signals; soluble ICAM-2-Ig fusion protein co-immobilized with anti-TCR mAb induced CD4+ T cell proliferation and IL-2R expression, and this costimulatory effect was almost completely inhibited by anti-CD11a or anti-CD18 mAbs.\",\n      \"method\": \"T cell proliferation assays with co-immobilized ICAM-2-Rg and anti-TCR mAb; blocking with anti-CD11a and anti-CD18 mAbs; CD25 expression analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ligand-receptor interaction demonstrated functionally with soluble Ig-fusion protein and replicated with blocking antibodies\",\n      \"pmids\": [\"1346150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"TCR complex crosslinking induces PKC-dependent association of CD11a/CD18 with the actin cytoskeleton; anti-CD3 mAb induced actin polymerization, colocalization of F-actin with LFA-1 by fluorescence microscopy, and LFA-1 immunoprecipitation from detergent-insoluble cytoskeletal fractions. This was blocked by the PKC inhibitor staurosporine or PKC desensitization, and accompanied by transient CD11a hyperphosphorylation.\",\n      \"method\": \"Fluorescence microscopy colocalization; immunoprecipitation from detergent-insoluble cytoskeletal fraction; PKC inhibitor (staurosporine); PKC desensitization; beta2-deficient T cell controls\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (microscopy, biochemical fractionation, IP, pharmacological inhibition, genetic controls)\",\n      \"pmids\": [\"1346786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Triggering of CD11a (LFA-1 alpha chain) by specific mAbs, but not anti-LFA-1 beta chain mAbs, induces homotypic adhesion in pre-activated (but not resting) T cells via LFA-1 itself; this requires an intact cytoskeleton (inhibited by cytochalasin B) and is sensitive to H7 (PKC/PKA inhibitor), implicating cytoskeletal reorganization and kinase signaling in LFA-1 alpha chain-mediated inside-out signaling.\",\n      \"method\": \"T cell homotypic aggregation assays; blocking mAbs against CD11a, CD18, ICAM-1; cytochalasin B and H7 inhibitor studies; temperature and divalent cation dependence tests\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection with multiple inhibitors, single lab\",\n      \"pmids\": [\"1352499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The CD11a gene promoter contains distinct cell-type-specific regulatory elements: the region -40 to -17 drives activity in T lymphocytes (Jurkat), and the first 17 bp relative to transcription start site drives activity in myeloid cells (HL-60); the 1.7 kb promoter is active only in leukocytes and not in non-leukocyte cell lines.\",\n      \"method\": \"Promoter cloning; transient expression assays with deletion reporter constructs in Jurkat, HL-60, and non-leukocyte cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional promoter deletion mapping in multiple cell lines, single lab\",\n      \"pmids\": [\"8097887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The CD11a promoter contains a 'LYM' box binding lymphoid/preerythroid and myeloid cell-specific DNA-binding activities, and a 'GAGA' sequence (RRRGAGGAAG) binding MS-1 (myeloid-specific, likely Ets family) and MS-2 (broadly expressed but developmentally regulated in myeloid cells), which control myeloid and lymphoid expression of CD11a.\",\n      \"method\": \"Promoter cloning and characterization; DNA-protein binding assays (EMSA); transient expression assays in lymphoid and myeloid cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cis-element mapping combined with DNA-binding activity characterization, single lab\",\n      \"pmids\": [\"8099450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"A synthetic peptide from residues 21–42 of the first Ig domain of ICAM-2 binds directly to purified CD11a/CD18 and inhibits endothelial cell adhesion to this integrin, as well as B lymphoblastoid cell binding to endothelial cells, identifying the ICAM-2 D1 region as the CD11a/CD18 binding site.\",\n      \"method\": \"Direct binding of synthetic peptide to purified CD11a/CD18; adhesion inhibition assays; leukocyte binding to peptide-coated plastic\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical binding to purified integrin with functional adhesion inhibition, single lab with multiple assays\",\n      \"pmids\": [\"8349630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CD11a/CD18 engagement enhances TNF-alpha and IL-2 mRNA expression (3- to 10-fold) in activated T cells; LFA-1-mediated homotypic aggregation and adhesion to ICAM-1 enhanced cytokine production, which was blocked by anti-CD11a, anti-CD18, or anti-ICAM-1 mAbs. Engagement of CD11a/CD18 on interaction with endothelial cells also enhanced cytokine production.\",\n      \"method\": \"Northern blot analysis of TNF-alpha mRNA; cytokine production assays; blocking with anti-CD11a, anti-CD18, anti-ICAM-1 mAbs; co-immobilized ICAM-1 adhesion assays\",\n      \"journal\": \"Cellular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional signaling assay with Northern blot readout and antibody inhibition, single lab\",\n      \"pmids\": [\"8098668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CD11a promoter activity is negatively regulated by sequences between -880 and -226, while the proximal region shows tissue-specific activity; the major transcription initiation site resembles an 'initiator' sequence; the -880/+83 fragment confers tissue-specific expression to reporter genes in leukocyte vs. non-leukocyte cell lines.\",\n      \"method\": \"CD11a promoter isolation; identification of transcription start sites; transient reporter gene expression assays with deletion constructs in LFA1+ and LFA1- cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional promoter deletion mapping in multiple cell lines, single lab\",\n      \"pmids\": [\"8103515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Crystal structures of the CD11a I-domain with no bound metal, bound Mg2+, and previously known Mn2+ show no major structural rearrangements at the metal-binding site; the cation-dependence of CD11a/CD18 ligand binding is therefore not explained by I-domain conformational change upon metal binding/removal, suggesting the metal ion participates directly in ligand contact or promotes favorable quaternary integrin arrangement.\",\n      \"method\": \"X-ray crystallography of CD11a I-domain with Mg2+ and without metal ion; structural comparison to previously solved Mn2+-bound structure\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures solved under multiple conditions with direct structural comparison; mechanistic interpretation supported by functional context\",\n      \"pmids\": [\"8805579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Telencephalin (TLN/ICAM-5), a neuronal glycoprotein with NH2-terminal Ig domains homologous to ICAMs, is a cellular ligand for CD11a/CD18; T cells and B lymphoblastoid cells bound to immunopurified recombinant TLN via CD11a/CD18, and TLN-transfected L cells bound purified CD11a/CD18; binding was inhibited by anti-CD11a/CD18 antibody.\",\n      \"method\": \"Cell adhesion assays to immunopurified recombinant TLN; reciprocal binding of TLN-transfected L cells to purified CD11a/CD18; antibody blocking; domain deletion analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding assays with purified proteins and transfected cells, multiple cell types, antibody blocking\",\n      \"pmids\": [\"8993013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Lovastatin binds to the I-domain of the CD11a alpha-chain, inhibiting LFA-1/ICAM-1 interaction; NMR spectroscopy and X-ray crystallography revealed the atomic details of lovastatin binding to the I-domain, representing an allosteric mechanism of LFA-1 inhibition distinct from ligand-competitive blocking.\",\n      \"method\": \"NMR spectroscopy; X-ray crystallography of lovastatin-I-domain complex; LFA-1/ICAM-1 interaction inhibition assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — two orthogonal structural methods (NMR + crystallography) with functional inhibition data in one study\",\n      \"pmids\": [\"10493852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The first Ig domain of ICAM-5 (telencephalin) is required for CD11a/CD18 binding; protein constructs containing the first Ig domain supported CD11a/CD18 interaction, while deletion of the first domain abolished binding; mAbs against the first domain completely blocked interaction. T cell binding to rat hippocampal neurons was blocked by anti-CD11a/CD18 and anti-ICAM-5 mAbs.\",\n      \"method\": \"Domain deletion constructs of ICAM-5; binding assays to CD11a/CD18; monoclonal antibody blocking; human T cell binding to rat hippocampal neurons\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain mapping with multiple deletion constructs, antibody blocking, and primary neuron binding assay\",\n      \"pmids\": [\"10741396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD11a/CD18 mediates initial neutrophil capture to ICAM-1 under shear stress (formyl peptide stimulation boosted capture efficiency ~4-fold via CD11a/CD18), while CD11b/CD18 is required for stable aggregate formation over sustained shear; these are sequential, cooperative steps in neutrophil adhesion to ICAM-1.\",\n      \"method\": \"Cone-plate viscometer shear assays; two-color flow cytometry measurement of heterotypic aggregates; monoclonal antibody blockade of CD11a and CD11b; ICAM-1-transfected target cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quantitative biophysical adhesion assay with selective antibody blockade, defined functional dissection of two integrin roles\",\n      \"pmids\": [\"10648403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Truncated beta2 subunit variants terminating after Q444 are sufficient for LFA-1 (CD11a/CD18) surface expression; surface-expressed LFA-1 variants with truncated beta2 are constitutively active for ICAM-1 adhesion and express the activation reporter epitope of mAb 24, indicating the major cysteine-rich region and conserved cysteines at 445/447/449 are not required for surface expression but their removal leads to constitutive activation.\",\n      \"method\": \"Transfection of truncated beta2 variants; flow cytometry for surface expression; ICAM-1 adhesion assays; mAb 24 activation epitope detection\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — structure-function analysis with multiple truncation mutants and functional adhesion assay, single lab\",\n      \"pmids\": [\"10946284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Endothelial cell-specific molecule-1 (ESM-1) binds directly to LFA-1 (CD11a/CD18) on lymphocytes, monocytes, and Jurkat cells; binding is divalent cation-dependent, saturable, and demonstrated by co-immunoprecipitation with anti-CD11a and anti-CD18 mAbs; real-time Biacore biosensor confirmed direct high-affinity interaction (Kd = 18.7 nM); ESM-1 dose-dependently inhibits soluble ICAM-1 binding to Jurkat cells.\",\n      \"method\": \"Co-immunoprecipitation with anti-CD11a and anti-CD18 mAbs; Biacore surface plasmon resonance kinetics; ICAM-1 competitive binding assay; Ca2+/Mg2+/Mn2+ dependence analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cell-free Biacore assay with Kd measurement plus reciprocal co-IP in two orthogonal systems confirming direct binding\",\n      \"pmids\": [\"11544294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Specific sequences flanking the ITGAL promoter (>500 bp 5' of transcription start site) are hypomethylated in lupus T cells and in T cells treated with 5-azacytidine or procainamide; patch methylation of this region suppresses ITGAL promoter function, demonstrating that DNA methylation changes at these sequences functionally regulate LFA-1 expression.\",\n      \"method\": \"Bisulfite sequencing of ITGAL promoter and flanking regions; patch methylation of promoter sequences in reporter constructs; T cells from lupus patients vs. healthy subjects\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — functional patch methylation assay directly linking specific methylation changes to promoter activity, validated in primary human lupus T cells and in vitro model\",\n      \"pmids\": [\"12115234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DNA methylation and chromatin structure contribute to tissue-specific CD11a expression; ITGAL promoter and 5' flanking regions are heavily methylated in fibroblasts (which do not express CD11a) but not in T cells; methylation correlates with closed chromatin (DNase I resistance); patch methylation of promoter and flanking regions suppresses ITGAL promoter function; treatment of fibroblasts with methylation inhibitor decreased promoter methylation and increased CD11a mRNA.\",\n      \"method\": \"Bisulfite sequencing; DNase I sensitivity assay; patch methylation of reporter constructs; 5-azacytidine treatment of fibroblasts; CD11a mRNA measurement\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal epigenetic methods with functional reporter assays and primary cell validation\",\n      \"pmids\": [\"12036881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Lck tyrosine kinase is required for surface expression and activation of CD11a/CD18 in T cells; Lck-deficient Jurkat cells (JCaM1.6) showed dramatically reduced CD11a/CD18 surface expression, reduced CD3- and PMA-induced adhesion to ICAM-1, accumulation of immature (incompletely glycosylated) CD18 not associated with CD11a, and re-transfection of Lck restored adhesion. Src-family kinase inhibitor PP2 also inhibited CD3-induced adhesion at concentrations blocking MAP kinase pathway.\",\n      \"method\": \"Lck-deficient Jurkat cell line (JCaM1.6); PP2 kinase inhibitor; flow cytometry for surface expression; cell surface labeling; ICAM-1 adhesion assays; Lck reconstitution by transfection\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (Lck-deficient line), pharmacological inhibition, and genetic rescue (Lck re-expression) all converge on same conclusion\",\n      \"pmids\": [\"12115650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Age-dependent hypomethylation of sequences flanking the ITGAL promoter correlates with increased CD11a mRNA expression in aging T cells; CD11a mRNA increases with age and with experimentally induced DNA hypomethylation; patch methylation of this region suppresses promoter function; DNA methyltransferases 1 and 3a decrease with aging.\",\n      \"method\": \"Bisulfite sequencing; patch methylation of promoter sequences in reporter constructs; CD11a mRNA measurement by RT-PCR; DNA methyltransferase activity measurement\",\n      \"journal\": \"Mechanisms of ageing and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional patch methylation reporter assay plus correlation of methyltransferase levels with gene expression, single lab\",\n      \"pmids\": [\"12020947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RUNX/AML and C/EBP factors regulate CD11a expression in myeloid cells through overlapping binding sites in the MS7 element of the CD11a promoter; C/EBP factors predominate in proliferating myeloid cells, while RUNX/AML factors (especially RUNX3/AML-2) bind in differentiated myeloid cells and increase CD11a/CD18 expression. AML-1/ETO inhibits CD11a promoter activity, explaining low CD11a/CD18 expression in t(8;21) myeloid leukemia cells.\",\n      \"method\": \"EMSA; ChIP; reporter gene assays with mutated MS7 elements; transfection of AML1B/CBFbeta and RUNX3; flow cytometry for CD11a/CD18 surface expression; comparison of myeloid cell lines and primary cells\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, EMSA, and functional reporter assays with mutants and overexpression, multiple transcription factors tested, mechanistic explanation validated in leukemia cells\",\n      \"pmids\": [\"12855590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Ly6C cross-linking induces clustering of LFA-1 (CD11a/CD18) on CD8 T cell surfaces via a mechanism dependent on actin cytoskeleton reorganization and calpain (intracellular protease) activity, but not PI3-kinase; LFA-1 clustering augments lymphocyte adhesion to endothelium in a capillary flow assay, and this is blocked by anti-LFA-1 mAb.\",\n      \"method\": \"Ly6C cross-linking; fluorescence microscopy of LFA-1 clustering; pharmacological inhibitors (cytochalasin, calpain inhibitor, PI3-kinase inhibitor); capillary flow-adhesion assay with blocking anti-LFA-1 mAb\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection of pathway with functional adhesion readout, single lab\",\n      \"pmids\": [\"12538687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RFX1 represses CD11a expression in CD4+ T cells by recruiting DNMT1, HDAC1, and histone methyltransferase SUV39H1 to the CD11a and CD70 promoters, maintaining DNA methylation, histone deacetylation, and H3K9 trimethylation; RFX1 downregulation in SLE reduces these repressive marks and causes CD11a overexpression. RFX1 co-immunoprecipitates with SUV39H1, and overexpressing/knocking down RFX1 controls H3K9me3 and CD11a expression levels.\",\n      \"method\": \"ChIP for H3K9me3 at CD11a promoter; co-immunoprecipitation of RFX1 and SUV39H1; RFX1 overexpression and siRNA knockdown; Western blot and immunofluorescence; RT-PCR for CD11a mRNA; SLE patient vs. healthy control CD4+ T cells\",\n      \"journal\": \"Journal of autoimmunity; Arthritis research & therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, co-IP, and gain/loss-of-function experiments across two publications from same lab with orthogonal methods\",\n      \"pmids\": [\"20223637\", \"21192791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD11a (ITGAL) is required for CD8+ T cell accumulation, activation, and proliferation in adipose tissue during obesity; CD11a-deficient obese mice showed dramatically reduced T cell infiltration, activation, and interferon-gamma expression in adipose tissue; adoptive transfer of CD11a-deficient CD8+ T cells failed to infiltrate adipose tissue of obese wild-type recipients, directly demonstrating a cell-intrinsic role for CD11a in T cell migration to adipose tissue.\",\n      \"method\": \"CD11a knockout mice; adoptive transfer of WT vs. CD11a-deficient CD8+ T cells; flow cytometry for T cell phenotype; in vitro stimulation with IL-12/IL-18; insulin resistance measurement\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout and adoptive transfer reconstitution experiment establish cell-intrinsic requirement, multiple orthogonal readouts\",\n      \"pmids\": [\"24158516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD11a deficiency in mice reduces the magnitude of the primary CD8 T cell response to Listeria monocytogenes, decreases differentiation into short-lived effector cells (KLRG1hi CD127lo), and greatly enhances generation of CD62L+ central memory cells; CD11b or CD11c deficiency had no effect, establishing a specific non-redundant role for CD11a in effector differentiation. Secondary responses were robust despite CD11a deficiency.\",\n      \"method\": \"CD11a-, CD11b-, and CD11c-deficient mice infected with L. monocytogenes; flow cytometry for KLRG1, CD127, CD62L, cytokine and granzyme B production\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic comparison of three single-knockout strains establishes specificity, multiple phenotypic readouts with defined effector/memory markers\",\n      \"pmids\": [\"23357382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Natural genetic variation in Itgal (including coding SNPs, a 5-bp insertion in exon 30b, and altered expression of a splice variant) modulates ischemic brain infarct volume; mice lacking Itgal showed increased neuronal cell death in ex vivo brain slice and in vivo focal cerebral ischemia models, placing CD11a in a pathway controlling neuroprotection after ischemia.\",\n      \"method\": \"Quantitative trait locus mapping; reciprocal recombinant congenic mice; SNP haplotype analysis; CD11a knockout mice in ex vivo brain slice and in vivo focal ischemia models\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — QTL mapping refined by genetic engineering, confirmed in multiple ischemia models with CD11a-deficient mice\",\n      \"pmids\": [\"24130503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Histone demethylase JMJD3 regulates CD11a expression in lupus CD4+ T cells by removing H3K27me3 from the ITGAL promoter; SLE patients showed decreased H3K27me3 and increased JMJD3 binding at the ITGAL promoter; JMJD3 overexpression in healthy donor CD4+ T cells reduced H3K27me3 at the ITGAL promoter and upregulated CD11a expression; JMJD3 siRNA in SLE cells reversed these effects.\",\n      \"method\": \"ChIP for H3K27me3 and JMJD3 at ITGAL promoter; JMJD3 overexpression (pcDNA3.1-JMJD3 transfection); JMJD3 siRNA knockdown; RT-PCR for CD11a; SLE patient vs. healthy control T cells\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP with gain and loss of function experiments, orthogonal molecular readouts, validated in both patient and healthy donor cells\",\n      \"pmids\": [\"28430662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) have distinct roles in neutrophil extravasation; using newly generated LFA-1 FRET (CD11a-YFP/CD18-CFP) and Mac-1 FRET mice with two-photon intravital imaging, LFA-1 was found to regulate neutrophil penetration through hotspot I (entry into the endothelial cell layer), while Mac-1 regulated transit through hotspot II (exit through basement membrane and pericyte sheath).\",\n      \"method\": \"Transgenic LFA-1 FRET (CD11a-YFP/CD18-CFP) and Mac-1 FRET mice; two-photon intravital imaging; transmission electron microscopy\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — novel FRET knockin mice with in vivo imaging, spatiotemporal dissection of extravasation with electron microscopy validation\",\n      \"pmids\": [\"30967528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A loss-of-function variant in Itgal (ITGAL/CD11a) in CC042 mice increases susceptibility to Salmonella Typhimurium infection; the causative role was confirmed by quantitative complementation test, indicating CD11a contributes to host defense against systemic Salmonella in a genetic background-dependent manner.\",\n      \"method\": \"F2 cross QTL mapping; quantitative complementation test with CD11a loss-of-function variant; bacterial load quantification; immune cell phenotyping\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complementation test directly confirms causality of Itgal variant, supported by QTL mapping\",\n      \"pmids\": [\"31636138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CD11a expressed on glioma-associated microglia (GAM) is required for CX3CR1 (Cx3cr1) expression, CX3CL1-directed microglia motility, and CCL5 (glioma mitogen) production; CD11a-knockout microglia showed reduced Cx3cr1 expression and impaired CX3CL1-directed migration. In vivo, antibody-mediated CD11a inhibition reduced Nf1 optic glioma growth in mice.\",\n      \"method\": \"CD11a-knockout mouse microglia in vitro functional studies; anti-CD11a neutralizing antibody treatment of Nf1 optic glioma mice in vivo; RNAScope and immunohistochemistry; RNA-seq meta-analysis\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout microglia in vitro and antibody inhibition in vivo with defined molecular mechanism (Cx3cr1 expression and Ccl5 production), validated in human specimens\",\n      \"pmids\": [\"34043012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Spermine-mediated suppression of LFA-1 expression is mechanistically linked to enhanced DNA methylation of the ITGAL promoter; inhibition of ornithine decarboxylase (reducing polyamines) decreased DNMT activity and enhanced ITGAL demethylation, increasing CD11a expression; spermine supplementation restored DNMT activity, enhanced ITGAL methylation, and reduced CD11a expression. Spermine acts by modulating the methyl donor SAM through effects on S-adenosyl-L-methionine decarboxylase.\",\n      \"method\": \"DFMO-mediated polyamine depletion; extracellular spermine supplementation; DNMT activity measurement; bisulfite sequencing of ITGAL promoter; CD11a protein expression (flow cytometry); SAM/decarboxylated-SAM manipulation; Western blot for Rap1\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological gain and loss of function with methylation and expression readouts, mechanistic pathway identified, single lab\",\n      \"pmids\": [\"23418509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Genetic deficiency of ItgaL (CD11a) completely prevents autoimmune diabetes development in NOD/LtJ mice and prevents insulitis, but through a mechanism distinct from Itgb2 deficiency: ItgaL deficiency does not alter NOD T cell adhesion to or transmigration across islet endothelial cells; adoptive transfer of ItgaL-deficient splenocytes into NOD/Rag-1 mice failed to cause diabetes, indicating ItgaL is required for T cell activation rather than adhesion/trafficking in this context.\",\n      \"method\": \"Gene-targeted ItgaL-deficient NOD/LtJ mice; insulitis and diabetes incidence monitoring; in vitro hydrodynamic flow adhesion studies with islet microvascular endothelial cells; adoptive transfer into NOD/Rag-1 mice\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with adoptive transfer and in vitro adhesion assays mechanistically distinguishing ItgaL from Itgb2 function\",\n      \"pmids\": [\"19223596\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ITGAL (CD11a) encodes the alpha-L subunit of the beta2-integrin LFA-1 (CD11a/CD18), which mediates leukocyte adhesion and immune cell activation by binding ligands ICAM-1, ICAM-2, ICAM-3, ICAM-5 (telencephalin), and ESM-1 through its I-domain (whose structure has been solved by X-ray crystallography and NMR, including a ligand-mimetic allosteric site targeted by lovastatin); inside-out activation of LFA-1 is regulated downstream of TCR signaling via PKC and Lck-dependent pathways that drive cytoskeletal association; CD11a expression is controlled at the transcriptional level by RUNX/AML and C/EBP transcription factors at the MS7 promoter element, and epigenetically by methylation of specific flanking ITGAL sequences (maintained by RFX1 recruiting DNMT1, HDAC1, and SUV39H1, and reversed by JMJD3-mediated H3K27 demethylation) that are aberrantly hypomethylated in SLE, aging, and systemic sclerosis leading to CD11a overexpression and autoreactivity; in vivo, CD11a plays defined roles in neutrophil capture at endothelial hotspot I during extravasation, CD8+ T cell effector differentiation and adipose tissue infiltration, microglia motility and glioma growth control, and protection against ischemic brain injury and Salmonella infection.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ITGAL encodes the alpha-L subunit (CD11a) that pairs with CD18 to form the beta2-integrin LFA-1, a central mediator of leukocyte adhesion, immune cell collaboration, and activation [#0, #2]. LFA-1 binds a family of immunoglobulin-superfamily counter-receptors through its CD11a I-domain: ICAM-1 [#0], ICAM-2 (via the first Ig domain) [#3, #8], the neuronal ligand telencephalin/ICAM-5 (first Ig domain required) [#12, #14], and the soluble endothelial factor ESM-1, which binds with high affinity and competes with ICAM-1 [#17]. Crystal and NMR structures of the I-domain established that cation dependence of ligand binding does not arise from metal-induced conformational change of the I-domain itself, and revealed an allosteric pocket where lovastatin binds to inhibit LFA-1/ICAM-1 engagement [#11, #13]. LFA-1 adhesiveness is controlled by inside-out signaling downstream of antigen-receptor and costimulatory inputs: TCR/CD3 crosslinking drives PKC-dependent association of CD11a/CD18 with the actin cytoskeleton [#4], the Src-family kinase Lck is required for CD11a/CD18 surface expression and ICAM-1 adhesion [#20], and CD40 signaling activates LFA-1-mediated homotypic adhesion in B cells [#1]. Functional engagement of LFA-1 enhances T-cell cytokine output and supports T cell-B cell collaboration and costimulation [#2, #3, #9]. ITGAL transcription is restricted to leukocytes through cell-type-specific proximal promoter elements and is driven in myeloid cells by RUNX/AML and C/EBP factors at the MS7 element [#6, #22], while DNA methylation of promoter-flanking sequences enforces tissue-restricted and quantitative control: this repressive state is maintained by RFX1-recruited DNMT1/HDAC1/SUV39H1 and by H3K27 trimethylation, and is reversed by JMJD3-mediated demethylation, with aberrant hypomethylation driving CD11a overexpression in lupus and aging T cells [#18, #19, #24, #28]. In vivo, CD11a directs neutrophil penetration of the endothelium during extravasation [#15, #29], CD8+ T cell effector differentiation and adipose-tissue infiltration [#25, #26], glioma-associated microglia motility and glioma growth [#31], and host responses in ischemic brain injury and Salmonella infection [#27, #30], and its loss prevents autoimmune diabetes by impairing T cell activation rather than trafficking [#33].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Established the founding adhesive function of LFA-1 by showing CD11a/CD18 mediates leukocyte adhesion to endothelium specifically through ICAM-1, distinct from CD11b/CD18.\",\n      \"evidence\": \"Monoclonal antibody blocking of PMN-endothelial adhesion with additive-inhibition analysis and surface down-modulation assays\",\n      \"pmids\": [\"2809204\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not define the I-domain residues contacting ICAM-1\", \"Does not address activation state of the integrin\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Demonstrated that LFA-1 adhesion is actively induced by immune signaling, linking CD40 and TCR-dependent T cell-B cell interactions to functional adhesion and B cell responses.\",\n      \"evidence\": \"B cell aggregation assays with CD40 truncation mutants and anti-CD18 blockade; T-B collaboration assays with anti-CD11a/CD18 blockade and IL-2 rescue\",\n      \"pmids\": [\"1706378\", \"1670945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular signaling pathway from CD40 to LFA-1 not resolved\", \"Does not identify the ligand on the partner cell biochemically\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Identified ICAM-2 as a second counter-receptor that delivers costimulatory signals and showed TCR crosslinking drives PKC-dependent LFA-1 association with actin, defining inside-out activation.\",\n      \"evidence\": \"T cell proliferation with co-immobilized ICAM-2-Ig; fluorescence colocalization and cytoskeletal-fraction IP with PKC inhibition; CD11a-specific mAb-triggered aggregation\",\n      \"pmids\": [\"1346150\", \"1346786\", \"1352499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of cytoskeletal adaptors linking LFA-1 to actin not defined\", \"Direct PKC substrate on the integrin tail not established\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Mapped the ICAM-2 binding region to its first Ig domain and defined the leukocyte-restricted, cell-type-specific architecture of the ITGAL promoter.\",\n      \"evidence\": \"Synthetic-peptide binding to purified CD11a/CD18 with adhesion inhibition; promoter deletion/reporter mapping and EMSA in lymphoid vs myeloid cell lines; cytokine mRNA induction assays\",\n      \"pmids\": [\"8349630\", \"8097887\", \"8099450\", \"8103515\", \"8098668\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific trans-acting factors at proximal elements not all identified\", \"Negative regulatory region between -880 and -226 mechanistically uncharacterized\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Resolved that I-domain cation dependence is not explained by metal-induced I-domain rearrangement, refining the structural basis of ligand binding.\",\n      \"evidence\": \"X-ray crystallography of the CD11a I-domain with Mg2+ and metal-free, compared to Mn2+-bound structure\",\n      \"pmids\": [\"8805579\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quaternary integrin rearrangement on activation not visualized\", \"Does not capture ligand-bound I-domain conformation\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Extended LFA-1's ligand repertoire to the nervous system by identifying telencephalin/ICAM-5 as a CD11a/CD18 ligand, later mapped to its first Ig domain.\",\n      \"evidence\": \"Adhesion of leukocytes to recombinant TLN and reciprocal binding of TLN-transfected cells; domain-deletion constructs and T cell binding to hippocampal neurons\",\n      \"pmids\": [\"8993013\", \"10741396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of leukocyte-neuron LFA-1/ICAM-5 binding not defined\", \"Affinity relative to ICAM-1/ICAM-2 not quantified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined a druggable allosteric site by determining lovastatin binds the I-domain to inhibit LFA-1/ICAM-1, distinct from competitive blockade.\",\n      \"evidence\": \"NMR and X-ray crystallography of the lovastatin-I-domain complex with functional inhibition assays\",\n      \"pmids\": [\"10493852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of statin binding to LFA-1 not addressed\", \"Allosteric coupling to ligand site not structurally traced\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Dissected the kinetics of adhesion, showing LFA-1 mediates initial neutrophil capture while constitutive activation can arise from beta2 cytoplasmic-region truncation.\",\n      \"evidence\": \"Shear-flow capture/aggregation assays with selective antibody blockade; transfection of truncated beta2 variants with mAb 24 activation-epitope detection\",\n      \"pmids\": [\"10648403\", \"10946284\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which beta2 truncation triggers constitutive activation not resolved\", \"Capture/stabilization handoff between LFA-1 and Mac-1 not molecularly defined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified ESM-1 as a soluble high-affinity LFA-1 ligand that competes with ICAM-1, implying a regulatory mode of adhesion control.\",\n      \"evidence\": \"Biacore SPR kinetics (Kd 18.7 nM), reciprocal co-IP with anti-CD11a/CD18, and ICAM-1 competition assays\",\n      \"pmids\": [\"11544294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological/in vivo role of ESM-1 antagonism of LFA-1 not established\", \"Binding site on the I-domain not mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Established that DNA methylation of ITGAL promoter-flanking sequences functionally and quantitatively controls CD11a expression, and that this is dysregulated in lupus and aging; Lck was shown to be required for CD11a/CD18 surface expression and activation.\",\n      \"evidence\": \"Bisulfite sequencing, patch-methylation reporter assays, DNase-I sensitivity, and azacytidine treatment in lupus, fibroblast, and aging T cell systems; Lck-deficient Jurkat line with PP2 inhibition and Lck rescue\",\n      \"pmids\": [\"12115234\", \"12036881\", \"12020947\", \"12115650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting machinery maintaining methylation not yet identified at this stage\", \"How Lck loss blocks CD11a/CD18 surface assembly mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined transcription-factor control of CD11a in myeloid cells via RUNX/AML and C/EBP at the MS7 element, explaining repression by AML1/ETO, and showed Ly6C-triggered LFA-1 clustering augments adhesion.\",\n      \"evidence\": \"ChIP, EMSA, MS7-mutant reporters, and RUNX/CBFbeta overexpression with surface flow cytometry; Ly6C crosslinking with cytoskeletal and calpain inhibitors in a flow-adhesion assay\",\n      \"pmids\": [\"12855590\", \"12538687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between RUNX/C/EBP control and DNA methylation not integrated\", \"Direct signaling intermediates of Ly6C-to-LFA-1 clustering not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified the repressive chromatin machinery, showing RFX1 recruits DNMT1, HDAC1, and SUV39H1 to maintain ITGAL methylation and H3K9me3, with loss driving lupus CD11a overexpression.\",\n      \"evidence\": \"ChIP for H3K9me3, RFX1-SUV39H1 co-IP, and RFX1 gain/loss-of-function in SLE vs control CD4+ T cells\",\n      \"pmids\": [\"20223637\", \"21192791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream cause of RFX1 downregulation in SLE not established\", \"Relative contribution of each recruited enzyme not separated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined non-redundant in vivo roles of CD11a in CD8+ T cell effector differentiation and adipose infiltration, in ischemic neuroprotection, in polyamine-linked methylation control, and in T cell activation underlying autoimmune diabetes.\",\n      \"evidence\": \"CD11a/CD11b/CD11c knockout mice in Listeria infection and obesity with adoptive transfer; QTL mapping and ischemia models; DFMO/spermine manipulation of DNMT activity and ITGAL methylation; ItgaL-deficient NOD mice with transfer and endothelial adhesion assays\",\n      \"pmids\": [\"23357382\", \"24158516\", \"24130503\", \"23418509\", \"19223596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific ligand engagements driving each in vivo phenotype not all defined\", \"How adhesion-independent CD11a contributes to T cell activation in diabetes unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Added the H3K27 axis to ITGAL epigenetic control, showing JMJD3 demethylates the promoter to upregulate CD11a in lupus T cells.\",\n      \"evidence\": \"ChIP for H3K27me3 and JMJD3 with JMJD3 overexpression and siRNA in SLE and healthy CD4+ T cells\",\n      \"pmids\": [\"28430662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger for increased JMJD3 recruitment in SLE not identified\", \"Interplay between H3K27 and DNA-methylation control not integrated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Spatially resolved LFA-1's extravasation role and confirmed a genetic requirement in host defense, separating LFA-1 (endothelial penetration) from Mac-1 (basement-membrane transit) and establishing causal Itgal contribution to Salmonella susceptibility.\",\n      \"evidence\": \"LFA-1 and Mac-1 FRET knockin mice with two-photon intravital imaging and TEM; QTL mapping with quantitative complementation of an Itgal loss-of-function variant\",\n      \"pmids\": [\"30967528\", \"31636138\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endothelial ligands distinguishing hotspot I from hotspot II not defined\", \"Mechanism by which CD11a affects Salmonella defense unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed a cell-intrinsic CD11a program in glioma-associated microglia controlling CX3CR1 expression, CX3CL1-directed motility, CCL5 production, and tumor growth.\",\n      \"evidence\": \"CD11a-knockout microglia in vitro and anti-CD11a antibody treatment of Nf1 optic glioma mice with RNAScope/IHC and human-specimen validation\",\n      \"pmids\": [\"34043012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling link from CD11a to Cx3cr1 transcription not defined\", \"Ligand engaged by microglial CD11a in the glioma microenvironment unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How distinct ligand engagements (ICAM-1/2, ICAM-5, ESM-1) are selected in specific tissues and how inside-out signaling, conformational activation, and ligand competition are integrated to produce the diverse in vivo functions of CD11a remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking activation state to tissue-specific ligand choice\", \"Mechanistic basis of adhesion-independent CD11a roles in T cell activation not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 3, 12, 15, 17]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 3, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4, 16, 20, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 2, 25, 26, 33]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [18, 22, 24, 28]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [19, 24, 28]}\n    ],\n    \"complexes\": [\"LFA-1 (CD11a/CD18)\"],\n    \"partners\": [\"ITGB2\", \"ICAM1\", \"ICAM2\", \"ICAM5\", \"ESM1\", \"LCK\", \"RFX1\", \"SUV39H1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}